|
[1]MAGISTRI P, TARANTINO G, BALLARIN R, et al.The evolving role of local treatments for hcc in the third millennium[J].Anticancer Res, 2017, 37 (2) :389-401.
|
|
[2]DUTTA R, MAHATO RI.Recent advances in hepatocellular carcinoma therapy[J].Pharmacol Ther, 2017, 173:106-117.
|
|
[3]BREKKEN RA, SAGE EH.SPARC, a matricellular protein:at the crossroads of cell-matrix communication[J].Matrix Biol, 2001, 19 (8) :816-827.
|
|
[4]PELLAGATTI A, JADERSTEN M, FORSBLOM AM, et al.Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q-syndrome patients[J].Proc Natl Acad Sci U S A, 2007, 104 (27) :11406-11411.
|
|
[5]TORRES-NUNEZ E, SUAREZ-BREGUA P, CAL L, et al.Molecular cloning and characterization of the matricellular protein Sparc/osteonectin in flatfish, Scophthalmus maximus, and its developmental stage-dependent transcriptional regulation during metamorphosis[J].Gene, 2015, 568 (2) :129-139.
|
|
[6]CHLENSKI A, COHN SL.Modulation of matrix remodeling by SPARC in neoplastic progression[J].Semin Cell Dev Biol, 2010, 21 (1) :55-65.
|
|
[7]SAID N.Roles of SPARC in urothelial carcinogenesis, progression and metastasis[J].Oncotarget, 2016, 7 (41) :67574-67585.
|
|
[8]RIVERA LB, BRADSHAW AD, BREKKEN RA.The regulatory function of SPARC in vascular biology[J].Cell Mol Life Sci, 2011, 68 (19) :3165-3173.
|
|
[9]BOYINENI J, TANPURE S, GNANAMONY M, et al.SPARC overexpression combined with radiation retards angiogenesis by suppressing VEGF-A via miR410 in human neuroblastoma cells[J].Int J Oncol, 2016, 49 (4) :1394-1406.
|
|
[10]LANE TF, SAGE EH.Functional mapping of SPARC:peptides from two distinct Ca+ (+) -binding sites modulate cell shape[J].J Cell Biol, 1990, 111 (6 Pt 2) :3065-3076.
|
|
[11]RAHMAN M, CHAN AP, TANG MJ, et al.Correction:a peptide of SPARC interferes with the interaction between Caspase8 and Bcl2to resensitize chemoresistant tumors and enhance their regression in vivo[J].PLo S One, 2015, 10 (4) :e0127226.
|
|
[12]CHLENSKI A, LIU S, BAKER LJ, et al.Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARC[J].Cancer Res, 2004, 64 (20) :7420-7425.
|
|
[13]FUNK SE, SAGE EH.The Ca2 (+) -binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells[J].Proc Natl Acad Sci U S A, 1991, 88 (7) :2648-2652.
|
|
[14]MAURER P, HOHENESTER E, ENGEL J.Extracellular calcium-binding proteins[J].Curr Opin Cell Biol, 1996, 8 (5) :609-617.
|
|
[15]KZHYSHKOWSKA J, KRUSELL L.Cross-talk between endocytic clearance and secretion in macrophages[J].Immunobiology, 2009, 214 (7) :576-593.
|
|
[16]KZHYSHKOWSKA J, WORKMAN G, CARDO-VILA M, et al.Novel function of alternatively activated macrophages:stabilin-1-mediated clearance of SPARC[J].J Immunol, 2006, 176 (10) :5825-5832.
|
|
[17]NAGARAJU GP, DONTULA R, EL-RAYES BF, et al.Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis[J].Carcinogenesis, 2014, 35 (5) :967-973.
|
|
[18]HUNG JY, YEN MC, JIAN SF, et al.Secreted protein acidic and rich in cysteine (SPARC) induces cell migration and epithelial mesenchymal transition through WNK1/snail in non-small cell lung cancer[J].Oncotarget, 2017, 8 (38) :63691-63702.
|
|
[19]CHEN Y, ZHANG Y, TAN Y, et al.Clinical significance of SPARC in esophageal squamous cell carcinoma[J].Biochem Biophys Res Commun, 2017, 492 (2) :184-191.
|
|
[20]KIM NI, KIM GE, LEE JS, et al.In phyllodes tumors of the breast expression of SPARC (osteonectin/BM40) mRNA by in situ hybridization correlates with protein expression by immunohistochemistry and is associated with tumor progression[J].Virchows Arch, 2017, 470 (1) :91-98.
|
|
[21]SALVATIERRA E, ALVAREZ MJ, LEISHMAN CC, et al.SPARC controls melanoma cell plasticity through Rac1[J].PLo S One, 2015, 10 (8) :e0134714.
|
|
[22]LIU H, XU Y, CHEN Y, et al.RNA interference against SPARC promotes the growth of U-87MG human malignant glioma cells[J].Oncol Lett, 2011, 2 (5) :985-990.
|
|
[23]ALAM R, SCHULTZ CR, GOLEMBIESKI WA, et al.PTEN suppresses SPARC-induced p MAPKAPK2 and inhibits SPARC-induced Ser78 HSP27 phosphorylation in glioma[J].Neuro Oncol, 2013, 15 (4) :451-461.
|
|
[24]LEE KS, BAE WK, BAE HG, et al.The fate of traumatic subdural hygroma in serial computed tomographic scans[J].J Korean Med Sci, 2000, 15 (5) :560-568.
|
|
[25]LI Z, LI AD, XU L, et al.SPARC expression in gastric cancer predicts poor prognosis:results from a clinical cohort, pooled analysis and GSEA assay[J].Oncotarget, 2016, 7 (43) :70211-70222.
|
|
[26]SHI D, JIANG K, FU Y, et al.Overexpression of SPARC correlates with poor prognosis in patients with cervical carcinoma and regulates cancer cell epithelial-mesenchymal transition[J].Oncol Lett, 2016, 11 (5) :3251-3258.
|
|
[27]LE BAIL B, FAOUZI S, BOUSSARIE L, et al.Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma[J].J Pathol, 1999, 189 (1) :46-52.
|
|
[28]SHIN M, MIZOKAMI A, KIM J, et al.Exogenous SPARC suppresses proliferation and migration of prostate cancer by interacting with integrin beta1[J].Prostate, 2013, 73 (11) :1159-1170.
|
|
[29]CHLENSKI A, DOBRATIC M, SALWEN HR, et al.Secreted protein acidic and rich in cysteine (SPARC) induces lipotoxicity in neuroblastoma by regulating transport of albumin complexed with fatty acids[J].Oncotarget, 2016, 7 (47) :77696-77706.
|
|
[30]LIU YP, HSIAO M.Exercise-induced SPARC prevents tumorigenesis of colon cancer[J].Gut, 2013, 62 (6) :810-811.
|
|
[31]RAHMAN M, CHAN AP, TANG M, et al.A peptide of SPARC interferes with the interaction between caspase8 and Bcl2 to resensitize chemoresistant tumors and enhance their regression in vivo[J].PLo S One, 2011, 6 (11) :e26390.
|
|
[32]CHEW A, SALAMA P, ROBBSHAW A, et al.SPARC, FOXP3, CD8and CD45 correlation with disease recurrence and long-term diseasefree survival in colorectal cancer[J].PLo S One, 2011, 6 (7) :e22047.
|
|
[33]LIANG JF, WANG HK, XIAO H, et al.Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer[J].J Exp Clin Cancer Res, 2010, 29:71.
|
|
[34]YU XZ, GUO ZY, DI Y, et al.The relationship between SPARC expression in primary tumor and metastatic lymph node of resected pancreatic cancer patients and patients'survival[J].Hepatobiliary Pancreat Dis Int, 2017, 16 (1) :104-109.
|
|
[35]JU MJ, QIU SJ, FAN J, et al.Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection[J].Am J Clin Pathol, 2009, 131 (4) :498-510.
|
|
[36]NAKATANI K, SEKI S, KAWADA N, et al.Expression of SPARC by activated hepatic stellate cells and its correlation with the stages of fibrogenesis in human chronic hepatitis[J].Virchows Arch, 2002, 441 (5) :466-474.
|
|
[37]LIN ZY, CHUANG WL.Genes responsible for the characteristics of primary cultured invasive phenotype hepatocellular carcinoma cells[J].Biomed Pharmacother, 2012, 66 (6) :454-458.
|
|
[38]DENG B, QU L, LI J, et al.MiRNA-211 suppresses cell proliferation, migration and invasion by targeting SPARC in human hepatocellular carcinoma[J].Sci Rep, 2016, 6:26679.
|
|
[39]ANG C, MIURA JT, GAMBLIN TC, et al.Comprehensive multiplatform biomarker analysis of 350 hepatocellular carcinomas identifies potential novel therapeutic options[J].J Surg Oncol, 2016, 113 (1) :55-61.
|
|
[40]LAU CP, POON RT, CHEUNG ST, et al.SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma[J].J Pathol, 2006, 210 (4) :459-468.
|
|
[41]ZHU XC, DONG QZ, ZHANG XF, et al.microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma[J].Int J Mol Med, 2012, 30 (6) :1321-1326.
|
|
[42]ZHANG Y, YANG B, DU Z, et al.Aberrant methylation of SPARC in human hepatocellular carcinoma and its clinical implication[J].World J Gastroenterol, 2012, 18 (17) :2043-2052.
|
|
[43]WAN J, WEN D, DONG L, et al.Establishment of monoclonal HCC cell lines with organ site-specific tropisms[J].BMC Cancer, 2015, 15:678.
|
|
[44]ATORRASAGASTI C, MALVICINI M, AQUINO JB, et al.Overexpression of SPARC obliterates the in vivo tumorigenicity of human hepatocellular carcinoma cells[J].Int J Cancer, 2010, 126 (11) :2726-2740.
|
|
[45]HUA HW, JIANG F, HUANG Q, et al.Re-sensitization of 5-FU resistance by SPARC through negative regulation of glucose metabolism in hepatocellular carcinoma[J].Tumour Biol, 2015, 36 (1) :303-313.
|
DownLoad: